Mimpara Granules *
Pharmacy Only: Prescription

  • Company:

    Amgen Ireland Ltd
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may be renewed (B)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Updated on 11 January 2022

File name

en_mimpara_ capsules_approved_pil_v71 XI and IE_1641900433.pdf

Reasons for updating

  • Change to MA holder contact details

Free text change information supplied by the pharmaceutical company

QRD v10.2

Updated on 27 February 2020

File name

en_mimpara_capsules_approved_spc_v65_1582818816.pdf

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.7 - Effects on ability to drive and use machines
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 5.2 - Pharmacokinetic properties
  • Change to section 6.1 - List of excipients
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 27 February 2020

File name

en_mimpara_ capsules_approved_pil_v65_1582818598.pdf

Reasons for updating

  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision
  • Change to other sources of information section

Updated on 27 August 2019

File name

en_mimpara capsules_approved_PIL_v55_1566900585.pdf

Reasons for updating

  • New PIL for new product

Updated on 27 August 2019

File name

en_mimpara_spc_capsules_v62__1566900488.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)